Targeting subchondral bone in osteoporotic osteoarthritis

Area of Science:

• Orthopedics and Musculoskeletal Diseases
• Bone Biology and Metabolism

Background:

• Osteoarthritis (OA) management can be personalized by identifying distinct disease phenotypes.
• Subchondral bone remodeling, influenced by formation and resorption rates, is crucial in OA pathogenesis.
• A specific phenotype, osteoporotic OA, is supported by in vivo, epidemiological, and clinical evidence.

Discussion:

• Subchondral bone, a key component in OA pathogenesis, exhibits varying remodeling patterns.
• The balance between bone formation and resorption dictates whether subchondral bone becomes sclerotic or osteoporotic.

Key Insights:

• Osteoporotic OA represents a specific disease phenotype characterized by altered subchondral bone remodeling.
• This phenotype suggests that bone-targeted therapies could be beneficial for affected patients.

Outlook:

• Further research into osteoporotic OA phenotypes may reveal novel therapeutic targets.
• Personalized treatment strategies focusing on subchondral bone could improve clinical and structural outcomes in OA.